Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis-Reference-Cited by-同舟云学术

Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis

Published:2017-05 Issue:5 Volume:112 Page:740-751
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:

Author:

McPherson Stuart,Hardy Tim,Dufour Jean-Francois,Petta Salvatore,Romero-Gomez Manuel,Allison Mike,Oliveira Claudia P,Francque Sven,Van Gaal Luc,Schattenberg Jörn M,Tiniakos Dina,Burt Alastair,Bugianesi Elisabetta,Ratziu Vlad,Day Christopher P,Anstee Quentin M

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference48 articles.

1. How big a problem is non-alcoholic fatty liver disease?;Anstee;BMJ,2011

2. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.;Chalasani;Hepatology,2012

3. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.;Browning;Hepatology,2004

4. Epidemiology of fatty liver: an update.;Bedogni;World J Gastroenterol,2014

5. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis.;Anstee;Nat Rev Gastroenterol Hepatol,2013

Cited by 582 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fibrosis-4 score for screening of metabolic dysfunction-associated steatotic liver disease (MASLD): Data from a population-based sample in Tuscany;Nutrition, Metabolism and Cardiovascular Diseases;2024-10

2. Diagnostic performance of new BAST score versus FIB-4 index in predicating of the liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease;European Journal of Medical Research;2024-09-14

3. Early screening for chronic liver disease: impact of a FIB-4 first integrated care pathway to identify patients with significant fibrosis;Scientific Reports;2024-09-05

4. Metabolic-Associated Fatty Liver Disease and Cognitive Performance in Type 2 Diabetes: Basal Data from the Phytate, Neurodegeneration and Diabetes (PHYND) Study;Biomedicines;2024-09-02

5. The steatosis-associated fibrosis estimator (SAFE) outperformed the FIB-4 score in screening the population for liver disease;Annals of Hepatology;2024-09